HPA Axis: New Clinical Developments
FP21-1
Sellar Hematoma Following Transsphenoidal Pituitary Surgery (TSS) Causing Acute Hypopituitarism: Clinical and Biochemical Characteristics
Katia El Sibai, Pratibha P Raghavendra, Warren Selman and Baha M Arafah
FP21-2
Increased Prevalence of Intracranial Meningiomas in Patients With ACTH-Independent Macronodular Adrenal Hyperplasia
Guilherme Asmar Alencar, Berenice B Mendonca, Mirian Y Nishi, Ana Claudia Latronico, Madson Q. Almeida, Antonio Marcondes Lerario and Maria Candida Barisson Villares Fragoso
FP21-3
Hypothalamic Pituitary Dysfunction Amongst Nasopharyngeal Cancer Survivors: An Increased Risk With The Use Of Concurrent Chemo-Irradiation
Jeyakantha Ratnasingam, N Karim, Alexander Tong Boon Tan, Shireene Vethakkan, Karen Choong and Siew Pheng Chan
FP21-4
Continuous Subcutaneous Hydrocortisone Infusion (CSHI) Improves Quality-of-Life in Addison's Disease (AD)
Marianne Oksnes, Sigridur Bjornsdottir, Magnus Isaksson, Roy Miodini Nilsen, Siri Carlsen, Olle Kämpe, Anna-Lena Hulting, Sophie Bensing, Eystein Sverre Husebye and Kristian Lovas
FP21-5
Endometrial Effects of Long-Term Mifepristone (MIFE) Treatment of Cushing's Syndrome: Results From the Seismic Studies
Ty Brian Carroll, Olga Ioffe, Irving M Spitz, Coleman Gross, David Cram and Amir Hekmat Hamrahian
FP21-6
Ovarian Hormone Suppression With Estradiol Add-Back Therapy in Premenopausal Women Reduces Dynamic HPA Axis Activity
Kathleen M Gavin, Ellie Gibbons, Anne Stavros, Tammie Nakamura, Karen L Villalon and Wendy M Kohrt